~~<i id='919F6E8CD6'><strike id='919F6E8CD6'><tt id='919F6E8CD6'><pre id='919F6E8CD6'></pre></tt></strike></i>~~

Home» focus» entertainment

entertainment

author：explore 2025-08-06 14:08:39 Page View：95227

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Woman gored by Bison at Yellowstone
Next article： Virginia high school admissions case could be legal follow

leisure time

DIEP, the 'gold standard' of breast reconstruction, is under threat

AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

Celiac disease study examines precisely how gluten triggers injury

AmicrographofCeliacdiseaseNephron/WikimediaCommonsForapersonwithceliacdisease,eatingabagelgoessometh

Walensky prepares to leave CDC — and Congress — behind

OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

The nurse manager staffing crisis is hurting patients

JaeC.Hong/APThoughtheCovid-19pandemicbroughtheightenedattentiontonursesoverall,auniquenursingrolehas